Dachaigh › Luchd-obrach › Capstan Therapeutics, Inc
Capstan Therapeutics, Inc: Tuarastalan H-1B agus taic bhìosa
Chuir Capstan Therapeutics, Inc 7 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 7. Tuarastal meadhanach a chaidh a thabhann: $140,000.
A bheil Capstan Therapeutics, Inc a’ toirt taic do bhìosaichean H-1B?
Chuir Capstan Therapeutics, Inc 7 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 10 Gearr 2025. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Senior Scientist | 2 | $120,000 |
| Research Associate, mRNA Production | 1 | $79,976 |
| Senior Scientist, RNA Platform | 1 | $70,824 |
| Associate Director, Analytical Development | 1 | $142,459 |
| Sr. Director | 1 | $171,080 |
| Sr. Director, Head of RNA Drug Substance | 1 | $241,910 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 2 | $89,988 |
| FY2024 | 3 | $140,000 |
| FY2025 | 2 | $206,495 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Medical Scientists, Except Epidemiologists3
- Molecular and Cellular Biologists2
- Natural Sciences Managers2
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Sr. Director, Head of RNA Drug Substance | $241,910–$289,230 Ìre III | San Diego, CA | 10 Gearr 2025 | 25 Iuch 2025 | Dearbhaichte |
| Sr. Director | $171,080–$250,000 Ìre II | San Diego, CA | 26 Samh 2024 | 14 Màrt 2025 | Dearbhaichte |
| Associate Director, Analytical Development | $142,459–$205,000 Ìre IV | San Diego, CA | 31 Cèit 2024 | 12 Ògmh 2024 | Dearbhaichte |
| Senior Scientist | $140,000–$150,000 Ìre II | San Diego, CA | 29 Faoi 2024 | 5 Gearr 2024 | Dearbhaichte |
| Senior Scientist, RNA Platform | $70,824–$157,000 Ìre I | San Diego, CA | 25 Dàmh 2023 | 27 Samh 2023 | Dearbhaichte |
| Senior Scientist | $100,000–$160,000 Ìre I | Philadelphia, PA | 19 Gibl 2023 | 1 Dàmh 2023 | Dearbhaichte |
| Research Associate, mRNA Production | $79,976–$90,000 Ìre II | San Diego, CA | 10 Dàmh 2022 | 24 Dàmh 2022 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).